Posts

Biopharma Job Market Report Q2 2026: Hiring Rebounds, Layoffs Ease, AI and R&D Talent in High Demand

on

Biopharma bites: Job cuts at Novartis, fresh funding for MeiraGTx and Fore, plus Boehringer's latest deal – 2026 update

on

Who pays the best (and worst) in biopharma? A look at typical employee salaries

on

Ligand to Acquire XOMA Royalty for $739 Million, Accelerating Profit Growth

on

Sun Pharma Strikes Biopharma's Largest Deal of 2026 with $11.75B Buyout of Organon

on

Biopharma Companies Encounter AI's Weak Spot: Scientific Context, Says Zifo

on

Agile Partnerships Drive Faster Pharma Innovation

on

Novartis CEO Vas Narasimhan Joins Anthropic Board to Advance Responsible AI in Healthcare

on

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

on

Post-Hoc Live: Biopharma M&A Surge Signals Industry Revival

on

Chugai Pharmaceutical Advances Innovation and Builds US Recognition in Biopharma

on

Recent Leadership Changes in Global Biopharma R&D (February 2026)

on

FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer

on

Biopharma Bites: Breakout Ventures' $114M AI Fund, Amid Funding Shifts

on

Biopharma Sentiment Index Q1 2026: Positive Outlook Amid Rally and Challenges

on

Biopharma Bites: Teva, Kinaset Funding Wins, Camzyos Teen Approval, Lynk and Lyra's Mixed Fortunes

on

Endpoints News Topics at 2026 JPM Healthcare Conference: CEOs, Investors, China, and Beyond

on

No public results for “Take the Biopharma Sentiment Index” Q1 2026 yet

on

Biopharma’s Winners and Losers of 2025 – Endpoints News recap

on

Recent news on Biopharma Sentiment Index (BPSI)

on